EverQuote Faces Challenges with Q3 Outlook and Q2 Results
EverQuote, the online insurance marketplace, faces challenges as its stock plummets after disappointing Q3 outlook and Q2 results. Analysts had higher expectations for revenue and predict a more moderate loss. Despite this, the company's CF...
Cybersecurity Stocks underperform as Analysts Update Outlooks
Analysts' updates on cybersecurity stocks have led to simultaneous upgrades and downgrades. Fortinet and Cloudflare face different outlooks as the sector remains unpredictable.
Nikola Stock: A Volatile Ride Continues
Nikola stock has seen significant fluctuations recently, with investors reacting to news and market conditions. Despite some setbacks, positive factors offer hope for the company's future.
Positive Start in US Markets with Futures Gaining
US markets start positively with futures for S&P 500 and Dow Jones Industrial Average gaining. European markets flat while Asian markets show mixed performance.
LPL Financial Announces Acquisition of Crown Capital Securities
LPL Financial acquires Crown Capital Securities, expanding its operations and services while maintaining Crown's independence and culture. The acquisition solidifies LPL's position in the industry.
Rathbones Group Increases Net Interest Income Guidance for 2023
Rathbones Group raises net interest income guidance for 2023 to £45 million due to larger-than-expected base rate rises. Company reports fall in pretax profit for first half of the year.
Pan American Silver to Sell Assets for $593 Million
Pan American Silver plans to sell assets worth $593 million, including the Mara project, Morococha mine, and Agua de la Falda project, to strengthen its balance sheet and focus on core assets. The sale will help reduce costs and increase ca...
Reserve Bank of Australia Maintains Official Cash Rate at 4.10%
The RBA maintains the official cash rate at 4.10% while remaining cautious about potential tightening in the future. Inflation and job market behavior will determine future policy decisions. Economists have mixed opinions about the RBA's de...
Revolution Medicines Inc. to Acquire EQRx Inc.
Revolution Medicines Inc. announces acquisition of EQRx Inc. in a $1 billion cash deal to support the development of RAS inhibitor drug candidates.
Atos Shares Plummet as Tech Foundations Business is Set to be Sold
Shares of French IT company Atos plummet as it announces discussions for the sale of its Tech Foundations business to Czech billionaire Daniel Kretinsky's investment company, with the transaction valued at 2 billion euros ($2.20 billion).